Targetid

Our video on the EU funded project TargetMI which continues to add more valuable data to the work we set up in TargetID.

https://www.youtube.com/watch?v=sylkIynnv7M

See also our website:
https://www.um.edu.mt/projects/targetmi/

TargetMI Project TargetMI is an EIC Pathfinder project at the forefront of research on Cardio genomics. In this project a high throughput multi-omic approach for the rapid di...

The latest feature on TargetID in The Sunday Times of Malta

TargetID: A novel strategy to find drug targets The extensive data obtained will be useful beyond the end of this project

Hemm hi!

Wara sentejn xogħol it-tim tal-proġett TargetID laħaq l-għan tiegħu. Żviluppajna strateġija bbażata fuq analisi tal-ġenom u l-prodott tiegħu, t-transcriptome, biex nagħrfu molekoli li għandhom il-potenzjal biex jiġu żvilluppati għal mediċini ġodda kontra l-Covid19. Issa ngħaddu l-bastun lil proġett ġdid BioGeMT: Bioinformatics for Genomics in Malta, b’fondi Ewropej mill-programm Horizon Europe fejn id-data, l-programmi u l-istrateġija ġdida li żviluppajna fil-proġett TargetID jistgħu jigu applikati biex ntejbu d-djanjosi u biex insibu mediċini ġodda għal ħafna aktar mard.

TargetID: Novel Drug Targets for Infectious Diseases huwa proġett li qed isir minn l-Università ta’ Malta b’fondi nazzjonali mill-COVID-19 R&D Fund 2020 amministrati mill-Kunsill Malti għax-Xjenza u t-Teknoloġija u Malta Enterprise.

And there it is!

Two years of work and the team has completed the project TargetID. We have developed a strategy that uses genomic and transcriptomic data to identify novel drug targets. The baton passes to our new project BioGeMT: Bioinformatics for Genomics in Malta funded through Horizon Europe where the data, the bioinformatic tools and the strategy we have developed in TargetID will be used to help improve diagnostics and find drug targets for many other diseases.

TargetID: Novel Drug Targets for Infectious Diseases is a University of Malta project funded through the COVID-19 R&D Fund 2020 jointly administered by the Malta Council for Science & Technology and Malta Enterprise.